HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Clearance Of OTC Final Rules Targeted For 2010 – ONP

This article was originally published in The Rose Sheet

Executive Summary

The Office of Nonprescription Products is aiming to wrap up pending over-the-counter final monographs by 2010, according to FDA officials

You may also be interested in...



FDA Clearance Process May Thwart 2010 Monograph Goal – ONP’s Ganley

The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA can improve its document-clearance process, according to ONP head Charles Ganley, MD

FDA Clearance Process May Thwart 2010 Monograph Goal – ONP’s Ganley

The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA can improve its document-clearance process, according to ONP head Charles Ganley, MD

L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter

L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection this fall, the company announced July 24

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel